Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Relmada Therapeutics Inc.

    NASDAQ: RLMD · Real-Time Price · USD
    0.60
    -0.02 (-2.61%)
    At close: Jul 02, 2025, 3:46 PM

    Relmada Therapeutics Revenue

    Relmada Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Relmada Therapeutics generated $0 in revenue.
    Revenue (ttm)
    $0
    Revenue Growth
    0%
    Price / Sales Ratio
    0
    Revenue / Employee
    $0
    Employees
    17
    Market Cap
    19.91M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist